Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Preventive Vaccines Market, 2021-2030”.
The report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain. The study also features a detailed analysis of the key drivers and trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes:
• A detailed assessment of the current market landscape, featuring clinical-stage preventive vaccines.
• A competitiveness analysis of preventive vaccine developers, featuring insightful pictorial summaries and representations.
• Elaborate profiles of the key preventive vaccine developers (shortlisted based on a proprietary criterion) across North America, Europe and Asia Pacific.
• An in-depth analysis of the completed, ongoing and planned trials of various preventive vaccines.
• An overview of the ongoing vaccine development initiatives for complex conditions, such as COVID-19, Ebola virus disease, HIV/AIDS, malaria and zika virus infection.
• An analysis of the investments made in this domain, during the period between 2015 and 2020 (till March).
• A case study on contract manufacturing landscape for vaccines, featuring the CMOs engaged in this domain.
Know more: https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html